GHST — what changed in the latest 10-Q
A section-by-section comparison of GHST's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-13 vs the prior 10-Q · 2026-02-11
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +6 | −7 | ~3 | 10 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | Text added/removed | 0 | 0 | ~1 | 0 |
| Other information | Text added/removed | 0 | 0 | ~1 | 16 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-13
Fiscal Quarter Ended March 31, 2026 Compared to the Fiscal Quarter Ended March 31, 2025
We had revenues of $0 in the three months ended March 31, 2026 and $4,755 in the three months ended 2025, and we sustained net losses of $25,587 and $31,532, respectively, in those periods. During the three months ended March 31, 2026 and 2025, expenses consisted primarily of general and administrat…
Nine Months Ended March 31, 2026 Compared to the Nine Months Ended March 31, 2025
We had revenues of $13,852 in the nine months ended March 31, 2026 and $55,359 in the nine months ended 2025, and we sustained net losses of $75,740 and $89,963, respectively, in those periods.
Our total operating expenses were $90,412 and $145,322 during the nine months ended March 31, 2026 and 2025, respectively, reflecting decreased general and administrative expenses of $77,373 in the 2026 period compared to $136,358 in the 2025 period and an increase in patent development costs of $13…
Text removed vs the prior filing · source: 10-Q · 2026-02-11
Three Months Ended December 31, 2025 Compared to the Three Months Ended December 31, 2024
We had $10,367 primarily in revenue in the three months ended December 31, 2025 compared to $4,872 for the three months ended December 31, 2024, and we sustained net losses of $15,935 and $45,714, respectively, in those periods. The lower losses resulted from decreased operating expenses in the 2025…
During the three months ended December 31, 2025 and 2024, operating expenses were $26,302 and $50,586, respectively, which consisted of general and administrative expenses, including professional fees for legal and financial services, and patent development costs.
Six Months Ended December 31, 2025 Compared to the Six Months Ended December 31, 2024
We had $13,852 in revenue in the six months ended December 31, 2025 compared to $50,604 for the six months ended December 31, 2024, and we sustained net losses of $50,153 and $58,431, respectively, in those periods.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice